A federal judge on Tuesday ordered a drug manufacturer that operated a plant in South Carolina to pay $10 million in connection with fraud.

ViroPharma Inc. said Tuesday an upcoming Food and Drug Administration advisory committee meeting will focus on general generic drug issues and not specifically on the company's only marketed treatment, Vancocin.

The Food and Drug Administration on Tuesday approved a new genetic test from Invitrogen Corp. which identifies breast cancer patients who will respond to a powerful cancer-fighting drug.

The Food and Drug Administration hopes to add its most serious warning label to epilepsy drugs, based on evidence they increase the risk of suicide in patients.

Drug developer Biopure Corp. said Monday it will file a study plan for its experimental blood substitute Hemopure with the Food and Drug Administration, months after the agency was criticized for its lack of action on potential safety risks associated with synthetic blood products.

Mexico's Agriculture Department is denying reports that the United States will close its borders to some Mexican produce.

Proposals for tougher heart-risk studies on new Type 2 diabetes drugs weighed heavy on shares of Amylin Pharmaceuticals Inc. and Novo Nordisk AS Thursday, since stricter regulations could mean longer, more costly clinical trials.

Adolor Corp. said Thursday the Food and Drug Administration has lifted its clinical hold on the company's Entereg drug in chronically constipated patients taking opioid pain drugs.

Generic drug maker Mylan Inc. said Thursday it received tentative approval from the Food and Drug Administration to market its 600 milligram linezolid tablets.

Drug developer and medical device maker Abbott Laboratories said Wednesday it received Food and Drug Administration approval for its anticipated drug-coated stent, Xience V.

Shares of Halozyme Therapeutics Inc. rose Tuesday after the biotechnology company said its Chemophase drug candidate met safety and tolerability goals in an early-to-midstage study.

Medical device maker Animas Corp., a subsidiary of Johnson & Johnson, said Tuesday the Food and Drug Administration approved an insulin pump that communicates wirelessly with a blood glucose meter to deliver insulin.

Government regulators are reconsidering how they approve diabetes drugs. They were criticized last year for their handling of heart risks connected with a widely used GlaxoSmithKline pill.

Johnson & Johnson's blockbuster anti-psychotic drug Risperdal will face generic competition, as Teva Pharmaceutical Industries Ltd. on Monday became the first company to receive approval for a generic version.

Johnson & Johnson's blockbuster anti-psychotic drug Risperdal will face generic competition, as Teva Pharmaceutical Industries Ltd. on Monday became the first company to receive approval for a generic version.